2020 Volume 96 Issue 1 Pages 35-39
Background and Aim: A new endoscopic band ligation (EBL) device was developed by Sumitomo Bakelite Co. Ltd. in 2018. This study aimed to evaluate the safety and efficacy of this new device.
Methods: A total of 22 patients treated with the new EBL device from December 2018 to August 2019 were included in this retrospective cohort study. We assessed rate of early re-bleeding (within 30 days of the initial EBL), total procedure time, rate of complete eversion of the diverticulum after EBL, and complications such as perforation.
Results: EBL was successfully completed in 20 cases (90.9%). The rate of early re-bleeding after EBL was 18.2% (4/22), while the median total procedure time was 42 minutes. The rate of complete eversion of the diverticulum after EBL was 75.0% (15/20). No complications, such as perforation, were noted in this study.
Conclusion: Our results suggest that the new EBL device is effective and safe for treating colonic diverticular bleeding.
